Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Murex Diagnostics UK subsidiary enters liquidation

This article was originally published in Clinica

Executive Summary

Murex Diagnostics (UK) has been forced into voluntary liquidation by a UK High Court ruling that it must post a £6 million interim security for infringement of Chiron's UK hepatitis C patent. The amount was more than the assets of the UK subsidiary of International Murex. The interim cash security, payable to Chiron and Ortho Diagnostics within seven days of the February 16th ruling, is not a final judgement on infringement damages which will be determined at a full enquiry in July (see Clinica No 680, p 16).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087399

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel